Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zengnan Mo

Showing results (51-60 of 267) with videos related to

Pageof 27
Sort By:
Oncology Reports|July 6, 2017
CtBP2 is associated with angiogenesis and regulates the apoptosis of prostate cancer cellsQiang Xuan, Xiaoge Zhong, Weidong Li, et al.
Frontiers in Surgery|January 30, 2023
The role of <i>CRYAB</i> in tumor prognosis and immune infiltration: A Pan-cancer analysisLang Cheng, Xiong Zou, Jiawei Wang, et al.
Translational Andrology and Urology|November 13, 2025
Combining single-cell and bulk RNA sequencing data to create a reliable prognostic model for predicting clear-cell renal cell carcinoma progressionYongchen Li, Jingwen Liu, Diman Mai, et al.
Oncotarget|April 20, 2017
Functional analysis implicating the SNP rs61552325 in ERBB2 as an effector for androgen-insensitive prostate cancer cell invasionXianxiang Xin, Yinmin Gu, Yang Chen, et al.
Translational Andrology and Urology|July 23, 2021
KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinomaShaohua Chen, Chengbang Wang, Xiaotao Su, et al.
Medical Oncology (Northwood, London, England)|January 26, 2010
A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge reviewChunming Gong, Xueying Hu, Yong Gao, et al.
Obesity Facts|May 18, 2022
Predicted Fat Mass, Lean Body Mass, and Risk of Hypertension: Results from a Chinese Male Cohort StudyMingli Li, Jiali Lin, Shuang Liang, et al.
Endocrine|April 1, 2026
Aldosterone fuels the progression of cardiovascular-kidney -metabolic syndrome: focus on primary aldosteronism spectrumHuannan Wei, Xinyang Long, Mingli Li, et al.
Metabolites|June 25, 2026
Lactate Metabolism Dysregulation Drives the Pathogenesis of Acute Kidney InjuryYongchen Li, Jingwen Liu, Diman Mai, et al.
Frontiers in Endocrinology|June 8, 2026
Metabolic-dimension CKM staging and cardiometabolic components predict incident MASLD: a longitudinal community-based cohort studyXinyang Long, Meihui Wu, YeMei Mo, et al.
Pageof 27

Showing results (51-60 of 267) with videos related to

Sort By:
Pageof 27
Oncology Reports|July 6, 2017
CtBP2 is associated with angiogenesis and regulates the apoptosis of prostate cancer cellsQiang Xuan, Xiaoge Zhong, Weidong Li, et al.
Frontiers in Surgery|January 30, 2023
The role of <i>CRYAB</i> in tumor prognosis and immune infiltration: A Pan-cancer analysisLang Cheng, Xiong Zou, Jiawei Wang, et al.
Translational Andrology and Urology|November 13, 2025
Combining single-cell and bulk RNA sequencing data to create a reliable prognostic model for predicting clear-cell renal cell carcinoma progressionYongchen Li, Jingwen Liu, Diman Mai, et al.
Oncotarget|April 20, 2017
Functional analysis implicating the SNP rs61552325 in ERBB2 as an effector for androgen-insensitive prostate cancer cell invasionXianxiang Xin, Yinmin Gu, Yang Chen, et al.
Translational Andrology and Urology|July 23, 2021
KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinomaShaohua Chen, Chengbang Wang, Xiaotao Su, et al.
Medical Oncology (Northwood, London, England)|January 26, 2010
A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge reviewChunming Gong, Xueying Hu, Yong Gao, et al.
Obesity Facts|May 18, 2022
Predicted Fat Mass, Lean Body Mass, and Risk of Hypertension: Results from a Chinese Male Cohort StudyMingli Li, Jiali Lin, Shuang Liang, et al.
Endocrine|April 1, 2026
Aldosterone fuels the progression of cardiovascular-kidney -metabolic syndrome: focus on primary aldosteronism spectrumHuannan Wei, Xinyang Long, Mingli Li, et al.
Metabolites|June 25, 2026
Lactate Metabolism Dysregulation Drives the Pathogenesis of Acute Kidney InjuryYongchen Li, Jingwen Liu, Diman Mai, et al.
Frontiers in Endocrinology|June 8, 2026
Metabolic-dimension CKM staging and cardiometabolic components predict incident MASLD: a longitudinal community-based cohort studyXinyang Long, Meihui Wu, YeMei Mo, et al.
Pageof 27